Bright Minds Biosciences Inc..
DRUG.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Bright Minds Biosciences Inc. is a biotechnology company focused on developing novel drugs for the treatment of neuropsychiatric disorders, epilepsy, and pain. The company's pipeline includes compounds targeting serotonin receptors, specifically designed to improve upon existing treatments by offeri...Show More
Better Health for All
0
Bright Minds Biosciences is entirely focused on developing novel drugs for serious neuropsychiatric disorders, epilepsy, and pain, indicating its entire business is devoted to health improvement. Preclinical data for BMB-101 showed complete elimination of drop attacks and 100% survival in a mouse model for epilepsy.
1
While BMB-201 demonstrated similar efficacy to morphine in preclinical pain models without opioid risks.
2
The company currently has no revenue-generating products. BMB-101 has completed Phase 1 clinical trials with 64 healthy volunteers,
3
showing it was safe and well-tolerated with no serious adverse events and only mild, transient adverse events.
4
The company is developing drugs for depression and other mental health conditions.
5
BMB-201's mechanism of action is designed to reduce dependency risks compared to morphine.
6
The Phase 1 clinical trial for BMB-101 was randomized, double-blind, and placebo-controlled.
7
However, the company maintains strong IP protection for BMB-101 until 2041, including potential patent term extension,
8
which suggests limited patent flexibility.
Fair Money & Economic Opportunity
0
No evidence available to assess Bright Minds Biosciences Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
The provided articles do not contain specific, quantitative data points for any of the KPIs related to Fair Pay & Worker Respect. While CEO compensation for 2024 is reported as CA$213.2k,
1
there is no information on median employee compensation, preventing the calculation of the CEO to median pay ratio.
2
The articles explicitly state the absence of data for living wage coverage, pay equity ratio, worker engagement, turnover, labor violations, insecure contracts, and health insurance coverage.
3
Fair Trade & Ethical Sourcing
0
No evidence available to assess Bright Minds Biosciences Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No specific, concrete data points or quantitative information regarding regulatory fines, transparency index scores, whistleblower policies, financial restatements, audit coverage, ESG controversy, complaint resolution times, board conflict-free percentages, anti-corruption policies, or third-party verification of ethical claims were found in the provided articles.
1
The available information explicitly states a lack of quantitative ethical or ESG metrics, and access to SEC data was throttled.
2
Kind to Animals
-60
Bright Minds Biosciences Inc. conducts animal testing, including repeat-dose oral toxicity studies in mice and dogs, and studies for BMB-101 in rodent models (mice and rats) and a zebrafish model.
1
There is no information provided regarding the use of alternative, non-animal testing methods for product safety and efficacy.
2
The company states its studies are Good Laboratory Practice (GLP) compliant,
3
but no formal animal testing policy regarding reduction, restriction, or prohibition of animal testing was found.
4
No War, No Weapons
0
The provided articles, an information circular for Bright Minds Biosciences Inc.'s 2025 AGM and a sustainability data page from Yahoo Finance, explicitly state that no data is available for any of the metrics related to the 'No War, No Weapons' ethical value.
1
Therefore, no KPIs can be scored based on the evidence provided.
Planet-Friendly Business
0
No specific, concrete data points related to Planet-Friendly Business KPIs were found in the provided articles. One article explicitly states that sustainability data for the company is currently unavailable.
1
Respect for Cultures & Communities
0
No evidence available to assess Bright Minds Biosciences Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
No specific, concrete evidence was found in the provided articles to assess Bright Minds Biosciences Inc. against any of the 'Safe & Smart Tech' KPIs. The articles primarily discuss clinical trial details and a collaboration involving a partner's FDA-cleared technology, but do not provide information on Bright Minds' own data protection, cybersecurity, or AI ethics practices.
1
Zero Waste & Sustainable Products
0
No evidence available to assess Bright Minds Biosciences Inc. on Zero Waste & Sustainable Products.